stockportfolio.pro
Stocks / ENSG vs TECH
ENSG vs TECH
The Ensign Group, Inc. and Bio-Techne Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| The Ensign Group, Inc. (ENSG) | Bio-Techne Corporation (TECH) | |
|---|---|---|
| Market cap | $8.9B | $8.5B |
| Revenue (latest FY) | $5.06B | $1.22B |
| Net income (latest FY) | $343.97M | $73.40M |
| Revenue growth (5y CAGR) | 16.1% | 10.5% |
| Net margin | 6.8% | 6.0% |
| Return on equity | 15.4% | 3.8% |
| P/E ratio | 24.6 | 77.7 |
| Dividend yield | 0.2% | 0.6% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | — | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ENSG — free Open TECH — freeFrequently asked questions
Which is bigger, ENSG or TECH?
The Ensign Group, Inc. is larger by market capitalization — $8.9B versus $8.5B.
Which grows faster, ENSG or TECH?
Over the last five fiscal years, The Ensign Group, Inc. grew revenue faster — 16.1%/yr versus 10.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.